American Heart Association

Please note: Seating is on a first-come, first-served basis. According to fire code, a session must and will be closed if the room is filled to capacity.

7:30-9 a.m.

Session VI: Concurrent Symposia A
Vasospasm and Neuroprotection
Room RO-6
This session has been jointly organized by the American Stroke Association, AANS/CNS Cerebrovascular Section and the Society of NeuroInterventional Surgery.

Moderators: Sepideh Amin Hanjani, M.D., Chicago, Ill.
Kai U. Frerichs, M.D., Boston, Mass.

7:30 Novel Neuroprotection Signaling in Experimental Stroke
Nicolas G. Bazan, New Orleans, La.

7:50 Basic Biology and Physiology of Vasospasm
R. Loch MacDonald, M.D., Ph.D., Toronto, Canada

8:10 Endovascular Management of Vasospasm
Theodore Larson, M.D., Denver, Colo.

8:30 Prophylactic Angioplasty, Is It Ever Indicated?
Richard E. Latchaw, M.D., Sacramento, Calif.

8:50 Discussion

Session VI: Concurrent Symposia B
Multidisciplinary Approach in Treatment of Cerebral Arteriovenous Malformations
Room RO-2
This session has been jointly organized by the American Stroke Association, AANS/CNS Cerebrovascular Section and the Society of NeuroInterventional Surgery.

Moderators: Robert W. Tarr, M.D., Cleveland, Ohio
Murat Gunel, M.D., FACS, New Haven, Conn.

7:30 Natural History and When to Treat
Robert D. Brown, Jr., M.D., M.P.H., FAHA, Rochester, Minn.

7:50 Aggressive Embolization
Saruhan Cekirge, M.D., Ankara, Turkey

8:10 Management of Intranidal Aneurysms in Inoperative Brain AVMs
Cameron G. McDougall, M.D., Phoenix, Ariz.

8:30 Aggressive Surgery
Christopher Ogilvy, M.D., Boston, Mass.

8:50 Discussion

Session VI: Concurrent Symposia C
Cost-effectiveness Studies in Stroke
Room La Louisianne A/B

Moderators: S. Claiborne Johnston, M.D., San Francisco, Calif.
Lewis B. Morgenstern, M.D., Ann Arbor, Mich.

7:30 Projected Cost of Stroke
Devin L. Brown, M.D., M.S., FAHA, Ann Arbor, Mich.

7:45 How to Incorporate Cost-effectiveness Analysis in Clinical Trials
David Matchar, M.D., FAHA, FACP, Durham, N.C.

8:00 Pharmacoeconomics of Stroke Treatment
Susan C. Fagan, Pharm.D., FAHA, Augusta, Ga.

8:15 How to Interpret Cost-effectiveness Data in Clinical Practice
Robert Holloway, Jr., M.D., M.P.H., Rochester, N.Y.

8:30 Discussion

Session VI: Concurrent D
Oral Abstract Presentations: Experimental Ischemia II
Room La Louisianne C

Moderators: Jun Chen, M.D., Pittsburgh, Pa.
Marilyn Cipolla, Ph.D., M.S., FAHA, Burlington, Vt.

7:30 Chronic Intermittent Mild Hypoglycemic Episodes Exacerbate Ischemic Damage In Streptozotocin-induced Diabetic Rats 50
Kunjan R. Dave, Antonello Pileggi, Isabel Saul, Miguel A. Perez-Pinzon, University of Miami, Miami, Fla.

7:42 Intracarotid Delivery Of CD49d FACS Sorted Neural Stem Cells Enhances Angiogenesis And Improves Functional Outcome After Experimental Stroke 51
Raphael Guzman, Alejandro De Los Angeles, Kevin Choo, Xavier Gaeta, Joey Cote, Samuel Cheshier, Gary K. Steinberg, Stanford University, Palo Alto, Calif.

7:54 Sex Differences in micro-RNA Expression in Cerebral Ischemia 52
Chad Siegel, Fudong Liu, Louise D. McCullough, University of Connecticut Health Center, Farmington, Conn.

8:06 The Role of Toll-Like Recptor(TLR) Signaling in Ischemic Precconditioning 53
Bolanle M. Famakin, Yongshan Mou, Ryo Ohtani, Christl A. Ruetzler, John M. Hallenbeck, National Institutes of Health, Bethesda, Md.

8:18 Chronic Soluble Epoxide Inhibition is Protective Against Cerebral Ischemia During Hypertension 54
Alexis N. Simpkins, R. Daniel Rudic, David Stepp, Derek A. Schreihofer, Siddhartha Roy, Medical College of Georgia, Augusta, Ga.; Bruce D. Hammock, University of California, Davis, Calif.; John D. Imig, Medical College of Georgia, Augusta, Ga.

8:30 Extended Timewindow For Neuroprotection By Thiazolidinediones Is Dependent On Time Of Reperfusion 55
Jorge Gamboa, University of Kentucky, Lexington; Nicole Victor, Gary Landreth, Sophia Sundararajan, Case Western Reserve University, Cleveland, Ohio

8:42 HSP27 Protects Against Neuronal Ischemia via Attenuation of Mitochondrial Signaling Pathways 56
R. Anne Stetler, Guodong Cao, Zhongfang Wang, Feng Zhang, University of Pittsburgh, Pittsburgh, Pa.; Yanqin Gao, Fudan University, Shanghai, China; Jun Chen, University of Pittsburgh, Pittsburgh, Pa.

8:54 Discussion

Session VI: Concurrent E
Oral Abstract Presentations: Recovery
Hall B 2-2

Moderators: Carolynn Patten, Ph.D., P.T., Gainesville, Fla.
Aninda B. Acharya, M.D., Saint Louis, Mo.

7:30 Ipsilateral Subventricular Zone is Activated After Acute Ischemic Stroke 57
Joan Marta-Fabregas, Hosp de la Santa Creu i Sant Pau, Barcelona, Spain; Jose Manuel Garcia-Verdugo, Miriam Romaguera-Ros, Ulises Gomez-Pinedo, Unidad Mixta CIPF-UVEG, Valencia, Spain; Isidre Ferrer, Hosp de Bellvitge, L'Hospitalet de Llobregat, Spain; Sergi Martinez-Ramerez, Marta Marqui, Luis Antonio Querol, Marc Suerez-Calvet, Daniel Alcolea, Josep-Lluis Marta-Vilalta, Hosp de la Santa Creu i Sant Pau, Barcelona, Spain

7:42 Improving Motor Function In Chronic Stroke Patients Using Simultaneous Occupational Therapy And TDCS 58
Dinesh Nair, Vijay Renga, Scott Hamelin, Alvaro Pascual-Leone, Gottfried Schlaug, Beth Israel Deaconess Medical Center, Boston, Mass.

7:54 Ropinirole In The Treatment Of Motor Deficits After Stroke: A Randomized, Placebo-Controlled, Double-Blind Study 59
Steven C. Cramer, University of California, Irvine, Orange, Calif.; Bruce H. Dobkin, UCLA, Los Angeles, Calif.; Elizabeth A. Noser, University of Texas, Houston, Houston, Texas; Rachelle W. Rodriguez, University of California, Irvine, Orange, Calif.; Lori A. Enney, GlaxoSmithKline, Research Triangle Park, N.C.

8:06 Prevalence And Characteristics Of Potential Subjects For Clinical Trials Of Early Post-stroke Upper Extremity Restoration 60
Alexander W. Dromerick, Georgetown University and National Rehabilitation Hospital, Washington, D.C.; Lucy E. Morris, Holly Hollingsworth, Washington University, St. Louis, Mo.; Dorothy F. Edwards, University of Wisconsin, Madison, Wis.; M Carolyn Baum, Washington University, St. Louis, Mo.

8:18 The Role Of The Right Hemisphere In Post-Stroke Language Recovery 61
Gottfried Schlaug, Andrea Norton, Sarah Marchina, Beth Israel Deaconess Medical Center, Boston, Mass.

8:30 Brief Psychosocial/Behavioral Intervention With Antidepressant Reduces Post-Stroke Depression Significantly More Than Antidepressant Alone 62
Pamela H. Mitchell, Kyra J. Becker, Ann Buzaitis, Kevin C. Cain, Michael Fruin, Ruth Kohen, Linda Teri, David Tirschwell, Richard Veith, University of Washington, Seattle, Wash.

8:42 Intravenous Transplantation Of Autologous Mesenchymal Stem Cells Derived From Bone Marrow Into Stroke Patients 63
Osamu Honmou, Kiyohiro Houkin, Department of Neurosurgery, Sapporo Medical University, Sapporo, Japan; Takuya Matsunaga, Forth Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan; Yoshiro Niitsu, Forth Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan; Sumio Ishiai, Department of Rehabilitation, Sapporo Medical University, Sapporo, Japan; Stephen G. Waxman, Jeffery D. Kocsis, Department of Neurology, Yale University School of Medicine, New Haven, Conn.

8:54 Discussion

9-9:10 a.m.
Short Break

9:10- 10:40 a.m.

Session VII: Concurrent Symposia A
Modern Management of Carotid Atherosclerotic Disease
Room RO-6
This session has been jointly organized by the American Stroke Association, AANS/CNS Cerebrovascular Section and the Society of NeuroInterventional Surgery.

Moderators: Avery Evans, Charlottesville, Va.
Brian Hoh, M.D., Gainesville, Fla.

9:10 How I Decide which Patients Get CAS, and which Patients Get CEA: The Perspective of a Physician that Performs Both
L. Nelson Hopkins, Buffalo, N.Y.

9:30 Neuropsychological Outcomes and Markers for Predicting Outcome after Carotid Treatment
E. Sander Connolly, Jr., M.D., New York, N.Y.

9:50 Management of Asymptomatic Carotid Stenosis
Aaron S Dumont, Charlottesville, Va.

10:10 Modern Imaging and Detection of Carotid Disease
Jeffrey Sunshine, M.D., Ph.D., Cleveland, Ohio

10:30 Discussion

Session VII: Concurrent Symposia B
Immunomodulation
Room La Louisianne C

Moderators: Ulrich Dirnagl, Berlin, Germany
Kyra Becker, M.D., Seattle, Wash.

9:10 Autoimmunuty in Stroke
Kyra Becker, M.D., Seattle, Wash.

9:35 Post-Stroke Immunodepression
Ulrich Dirnagl, Berlin, Germany

10 Killing the Messenger: Stroke Effects on Peripheral Immune System
Patricia D. Hurn, Ph.D., FAHA, Portland, Ore.

10:25 Discussion

Session VII: Concurrent Symposia C
Technology: Replacement of Lost CNS Function
Room La Louisianne A/B

Moderator: John Chae, M.D., Cleveland, Ohio

9:10 Functional Electrical Stimulation
John Chae, M.D., Cleveland, Ohio

9:30 Brain Computer Interface
Leigh R. Hochberg, M.D., Ph.D., Boston, Mass.

9:50 Exoskeletal Approaches to Restoring Motor Function
JiPing He, Tempe, Ariz.

10:10 Bions
Jane Burridge, Southampton, United Kingdom

10:30 Discussion

Session VII: Concurrent D
Oral Abstract Presentations: Vascular Cognitive Impairment
Room RO-2

Moderator: Steven M. Greenberg, M.D., Ph.D., Boston, Mass.

9:10 Hypertension is Associated with Hippocampal Sclerosis 64
Amytis Towfighi, Ling Zheng, Univ of Southern California, Los Angeles, Calif.; William Ellis, University of California, Davis, Calif.; Wendy Mack, University of Southern California, Los Angeles, Calif.; Harry V. Vinters, University of California, Los Angeles, Calif.; Helena C. Chui, Chris Zarow, University of Southern California, Los Angeles, Calif.

9:22 Morphological Changes of Cortical Sulci in Cerebral Small Vessel Diseases: a 3D MRI Study in CADASIL 65
Eric Jouvent, Department of Neurology, Hop Lariboisiere, Paris, France; Jean-Francois Mangin, Neurospin, I2BM, Saclay, France; Raphael Porcher, Dept of Biostatistics, Hop Saint-Louis, Paris, France; Anand Viswanathan, Department of Neurology and Clinical Trials Unit, Massachussets General Hospital and Harvard Medical School, Boston, Mass.; Mike O'Sullivan, Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-Univ, Munich, Germany; Jean-Pierre Guichard, Department of Radiology, Hop Lariboisiere, Paris, France; Martin Dichgans, Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-Univ, Munich, Germany; Marie-Germaine Bousser, Hugues Chabriat, Department of Neurology, Hop Lariboisiere, Paris, France

9:34 Association Between Increased Diastolic Blood Pressure Levels And Cognitive Impairment: The Reasons For Geographic And Racial Differences In Stroke (REGARDS) Study 66
Georgios Tsivgoulis, Andrei V. Alexandrov, Comprehensive Stroke Center, University of Alabama at Birmingham Hospital, Birmingham, Ala.; Virginia V. Wadley, Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala.; Frederick V. Unverzagt, Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Ind.; Rodney C. Go, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Ala.; Claudia S. Moy, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.; Brett Kissela, Department of Neurology, University of Cincinnati, Cincinnati, Ohio; George Howard, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Ala.

9:46 Heterogeneity In The Relationships Between Blood Pressure, White Matter Lesion Volume And Cognitive Function In Patients With Small Vessel 67
Jonathan Birns, King's College London School of Medicine, London, United Kingdom; Jozef Jarosz, King's College Hospital, London, United Kingdom; Robin Morris, Institute of Psychiatry, London, United Kingdom; Hugh Markus, St George's, University of London, London, United Kingdom; Lalit Kalra, King's College London School of Medicine, London, United Kingdom

9:58 Tissue Microstructural Changes Are Independently Associated with Pre-Index Cognitive Impairment in Survivors of Lobar Intracerebral Hemorrhage 68
Anand Viswanathan, Pratik Patel, Rosanna Rahman, R. N. Nandigam, Catherine Kinnecom, Massachusetts General Hospital, Boston, Mass.; Luc Bracoud, Bio-Imaging Technologies SAS, Lyon, France; Jonathan Rosand, Massachusetts General Hosp, Boston, MA; Hugues Chabriat, Dept of Neurology, CHU Lariboisire, Assistance Publique des Hopitaux de Paris, Paris, France; Steven M. Greenberg, Eric E. Smith, Massachusetts General Hosp, Boston, Mass.

10:10 The Metabolic Syndrome and Cognitive Function in Healthy Middle-Aged and Older Adults without Diabetes 69
Nicole M Gatto, USC, Los Angeles, Calif.; Victor W. Henderson, Stanford, Stanford, Calif.; Jan A. St. John, Carol McCleary, Howard N. Hodis, Wendy J. Mack, USC, Los Angeles, Calif.

10:22 Cortical Grey Matter Volume is Reduced in Patients at High-Risk for Vascular Events 70
Nerses Sanossian, Ling Zheng, Wendy Mack, University of Southern California, Los Angeles, Calif.; Michael W. Weiner, University of California San Fransisco, San Fransisco, Calif.; William J. Jagust, University of California, Berkely, Berkeley, Calif.; Charles C. DeCarli, Dan Mungas, University of California, Davis, Sacramento, Calif.; Bruce R. Reed, University of California, Davis, Martinez, Calfi.; Joel H. Kramer, University of California San Fransisco, San Fransisco, Calif.; Helena C. Chui, University of Southern California, Los Angeles, Calif.

10:34 Discussion

Session VII: Concurrent E
Oral Abstract Presentations: Pediatric Stroke
Hall B 2-2

Moderators: Warren Lo, Columbus, M.D., Ohio
Meredith R Golomb, M.D., M.S., Indianapolis, Ind.

9:10 Neurovascular Phenotypes in Children with Familial Intracranial Arterial Aneurysms 71
Todd Abruzzo, University of Cincinnati Medical Center, Cincinnati, Ohio; L. Seranno, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; D. Kleindorfer, B. Jones, University of Cincinnati Medical Center, Cincinnati, Ohio; F. Mangano, L. Sauerbeck, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; A. Greely, University of Cincinnati Medical Center, Cincinnati, Ohio; N. Zumberge, Columbus Children's Hospital, Columbus, Ohio; K. Crone, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; J. Broderick, University of Cincinnati Medical Center, Cincinnati, Ohio

9:22 Bilateral Corticospinal Tract Degeneration After Unilateral Stroke in Hemiparetic Children: A TMS and MRI Study 72
Adam Kirton, Alberta Children's Hospital, Calgary, AB, Canada; Trish Domi, Hospital for Sick Children, Toronto, Ontario, Canada; Robert Chen, Toronto Western Res Institute, Toronto, Ontario, Canada; Manohar Shroff, Elizabeth Kouzmitcheva, Hospital for Sick Children, Toronto, Ontario, Canada; Carolyn Gunraj, Toronto Western Res Institute, Toronto, Ontario, Canada; Gabrielle deVeber, Hospital for Sick Children, Toronto, Ontario, Canada

9:34 Childhood Ischemic Stroke Is More Common in Boys: Findings from the International Paediatric Stroke Study 73
Meredith Golomb, Riley Hospital, Indianapolis, Ind.; Heather Fullerton, University of California San Francisco, San Francisco, Calif.; Gabrielle deVeber, The Hospital for Sick Children, Toronto, Ontario, Canada; and members of the International Pediatric Stroke Study

9:46 Prevalence and Predictors of Perinatal Hemorrhagic Stroke 74
Jennifer Armstrong-Wells, S. Claiborne Johnston, Yvonne W. Wu, UC San Francisco, San Francisco, Calif.; Steven Sidney, Kaiser Permanente Medical Center, Oakland, Calfi.; Heather J. Fullerton, UC San Francisco, San Francisco, Calif.

9:58 Expanded Case Identification Methods Yield a Higher Incidence of Pediatric Stroke 75
Nidhi Agrawal, S. Claiborne Johnston, Yvonne W. Wu, UCSF, San Francisco, Calif.; Stephen Sidney, Kaiser Permanente, San Francisco, Calif.; Heather J. Fullerton, UCSF, San Francisco, Calif.

10:10 Nitrative Stress Induces Cerebral Microvascular Degeneration Via The Production Of Trans-Arachidonic Acids: Role Of Hypercapnia 76
Jean-Claude Honore, Amna Kooli, Elsa Kermorvant-Duchemin, Sainte-Justine Res Center, Montreal, QC, Canada; Florian Sennlaub, INSERM U598 - Ctr des Cordeliers, Paris, France; Michael Balazy, Department of Pharmacology - New York Medical College, Valhala, N.Y.; Sylvain Chemtob, Sainte-Justine Res Center, Montreal, QC, Canada

10:22 Secretory Phospholipase A2 is Involved in Hypoxic Cerebrovascular Injury in the Newborn Piglet 77
Ferenc Bari, Aliz Zimmermann, Univ of Szeged, Szeged, Hungary; Jana Pardeike, Free Univ, Berlin, Germany; Eszter Farkas, Ferenc Domoki, University of Szeged, Szeged, Hungary

10:34 Discussion

10:40-11:10 a.m.
Exhibits/Break
Hall A

11:10 a.m.-12:45 p.m.

Session VIII: Plenary Session II
Hall B 2

Moderators: Philip B. Gorelick, M.D., M.P.H., FACP, Chicago, Ill.
Patricia D. Hurn, Ph.D., FAHA, Portland, Ore.

11:10 Siekert and Globus Award Presentations
Patricia D. Hurn, Ph.D., FAHA, Portland, Ore.

Presentation of the Robert G Siekert New Investigator Award
Pooja Khatri, M.D., Cincinnati, Ohio
(Presenting oral abstract 130 - Good Outcome after Technically Successful Intra-Arterial Therapy is Time-Dependent - on Friday morning.)

Presentation of the Mordecai Y T Globus New Investigator Award
Hans Worthmann, M.D., Hannover, Germany
(Presenting oral abstract 84 - Early Inflammation after TIA or Ischemic Stroke: Different MMP-9 Time Courses predict Stroke Severity on Thursday afternoon.)

11:20 Introduction of the William M. Feinberg Award for Excellence in Clinical Stroke
Patricia D. Hurn, Ph.D., FAHA, Portland, Ore.

11:25 William M. Feinberg Award for Excellence in Clinical Stroke Lecture
Prioritizing Research in Stroke
S. Claiborne Johnston, M.D., Ph.D., San Francisco, Calif.

11:45 A Tribute to Dr. Julian Hoff, M.D., FAHA
Lewis B Morgenstern, MD, Ann Arbor, Mich.

11:50 A Tribute to Dr. Robert Hobson, M.D.
Thomas G Brott, MD, Jacksonville, Fla.

Plenary Symposium
Cerebral Hemorrhage: An Overview

Moderators: Frank Sharp, M.D., Sacramento, Calif.
E. Sander Connolly, Jr., M.D., New York, N.Y.

11:55 Mechanisms of Secondary Injury After Cerebral Hemorrhage
Guohua Xi, M.D., Ann Arbor, Mich.

12:11 MR Imaging in Cerebral Hemorrhage - Clinical and Research Applications
Christine Anne Wijman, M.D., Palo Alto, Calif.

12:28 Hemostatic Therapy in Cerebral Hemorrhage: End of the Road or the Beginning of a Journey?
Thorsten G. Steiner, M.D., Ph.D., Heidelberg, Germany

12:45-2 p.m.
Exhibits and Lunch Break
Hall A

Fellow and Early Career Luncheon: How to be Successful in Obtaining Independent Grant Funding
(ticket required; seating is limited)
Room 220 - 222

2-3:30 p.m.

Session IX: Concurrent Symposia A
Management of Massive Ischemic Stroke
Room La Louisianne A/B

Moderators: Michael D. Hill, M.D., M.S., FRCPC, Calgary, Canada
Jose Suarez, M.D., Houston, Texas

2 The Role of Osmotherapy and Fluid Management in Stroke
Alejandro A Rabinstein, M.D., Rochester, Minn.

2:20 Early Decompressive Hemicraniectomy for Malignant Hemispheric Infarction
Werner Hacke, M.D., FAHA, Heidelberg, Germany

2:40 Monitoring Massive Stroke: Noninvasive and Invasive Techniques
Michael DeGeorgia, M.D., Cleveland, Ohio

3 Respiratory and Glucose Management in Acute Stroke
William Coplin, M.D., Detroit, Mich.

3:20 Discussion

Session IX: Concurrent Symposia B
Pediatric Cerebral Sinovenous Thrombosis: Insights from the Field
Hall B 2-2

Moderators: Donna M. Ferriero, M.D., San Francisco, Calif.
Gabrielle A. deVeber, M.D., Toronto, Canada

2 Epidemiology of Pediatric CSVT
Gabrielle A. deVeber, M.D., Toronto, Canada

2:20 Diagnosis
Fenella J. Kirkham, M.A., M.B., London, United Kingdon

2:40 Pediatric CSVT: Rationale for Treatment
Patricia Massicotte, M.D., Edmonton, AB, Canada

3 Pediatric CSVT: Treatment Safety and Outcomes
Mahendranath Moharir, M.D., Westmead NSW, Australia

3:20 Discussion

Session IX: Concurrent C
Oral Abstract Presentations: Ischemia/Vasospasm
Room RO-6

Moderators: Kadir Erkmen, M.D., Lebanon, N.H.
G. Edward Vates, M.D., Ph.D., Rochester, N.Y.

2 Single Center Experience With Combined (Thrombolytics and Mechanical Thrombectomy) Intra-arterial Intervention In 112 Consecutive Patients With Angiographically Confirmed Large Vessel Thromboembolic Ischemic Stroke (1-6 hours post symptom onset) from 2003 to 2007 78
Michael T. Madison, James K. Goddard III., Jeffrey P. Lassig, Mark E. Myers, St. Paul Radiology, Saint Paul, Minn.

2:12 Pre-ischemic Upregulation of TNF-? induced by Physical Exercise Reduces Brain Inflammation via ERK1/2 Signaling in Stroke 79
Alecia Curry, Brandon Leibelt, Ryan Rogers, Will Davis, Shane Sprague, David F. Jimenez, Yuchuan Ding, University Texas Health Science Center, San Antonio, Texas

2:24 Optimal tPA Concentration for 120 kHz Ultrasound Enhanced Thrombolysis 80
George J. Shaw, Jason M. Meunier, Christopher J. Lindsell, Christy K. Holland, University of Cincinnati, Cincinnati, Ohio

2:36 Cerebral Ischemia Results In A Varying Degree Of Reduction Of Cerebral Blood Flow In Gray And White Matter 81
Quan Zhu, Duke University, Durham, N.C.; Jin-Moo Lee, Katie Vo, Washington University, St. Louis, Mo.; Weili Lin, University of North Carolina, Chapel Hill, N.C.

2:48 Electrical Stimulation of the Cervical Spinal Cord Resolves Cerebral Vasospasm following Subarachnoid Hemorrhage in Rats 82
Jin-Yul Lee, Dah-Luen Huang, Richard Keep, Oren Sagher, Crosby Neurosurgical Labs, Ann Arbor, Mich.

3 The Role of the Haptoglobin Genotype in the Development of Chronic Vasospasm After Experimental Subarachnoid Hemorrhage 83
Kaisorn L. Chaichana, Johns Hopkins School of Medicine, Baltimore, Md.; Andrew P. Levy, Rachel Lotan-Miller, Technion-Israel Institute of Technology, Haifa, Israel; Sophia Shakur, Rafael Tamargo, Johns Hopkins School of Medicine, Baltimore, Md.

3:12 Early Inflammation after TIA or Ischemic Stroke: Different MMP-9 Time Courses predict Stroke Severity 84
Hans Worthmann, Anita Blanka Tryc, Argyro Tountopoulou, Annemarie Goldbecker, Reinhard Dengler, Ralf Lichtinghagen, Karin Weissenborn, Medical School Hannover, Hannover, Germany

3:24 Discussion

Session IX: Concurrent D
Oral Abstract Presentations: Nursing and Rehabilitation Professions
Room RO-2

Moderator: Susan E. Wehner, M.S.N., N.P., Lansing, Mich.

2 Neuroanatomical Basis of Swallowing Disorders after Stroke 85
Marlis Gonzalez-Fernandez, Jonathan T. Kleinman, Paul Ky, Jeffrey B. Palmer, Argye E. Hillis, Johns Hopkins University School of Medicine, Baltimore, Md.

2:12 The Plasticity of Swallowing Center in the Brain 86
Jing Zhang, Xingquan Zhao, Chunxue Wang, Yongjun Wang, BeijingTiantan Hosp Affiliated to Capital Medical Univ, Beijing, China

2:24 Femoral Artery Blood Flow Velocity and Diameter Changes in the Hemiparetic Limb in Chronic Stroke 87
Sandra A. Billinger, Benjamin Y. Tseng, Patricia M. Kluding, University of Kansas Medical Center, Kansas City, Kan.

2:36 One Year Follow-up Of Patients Who Are Using The Ness L300 Neuroprosthesis: Effects On Gait Performance 88
Gad Alon, University of Maryland School of Medicine, Baltimore, Md.; Jeffery M. Hausdorff, Harvard Medical School, Boston, Mass.; Haim Ring, Sackler Faculty of Medicine, Tel-Aviv Univ, Tel-Aviv, Israel

2:48 Efficacious Affected Arm Rehabilitation Via the Internet; Using Inexpensive, Remote Technology to Deliver Electrical Stimulation 89
Stephen Page, Valerie Hill, Peter Levine, University of Cincinnati, Cincinnati, Ohio; Amanda Herzog, Rachel Jordan, Maura Hoefner, Xavier University, Cincinnati, Ohio

3:00 Stroke Caregiver Outcomes from the Telephone Assessment and Skill-Building Kit (TASK) 90
Tamilyn Bakas, Indiana University School of Nursing, Indianapolis, Ind.; Carol J. Farran, Rush University School of Nursing, Chicago, Ill.; Joan K. Austin, Indiana University School of Nursing, Indianapolis, Ind.; Barbara A. Given, Michigan State University College of Nursing, East Lansing, Mich.; Susan M. Perkins, Indiana University School of Medicine, Indianapolis, Ind.; Elizabeth A. Johnson, Indiana University School of Nursing, Indianapolis, Ind.; Linda S. Williams, Indiana University School of Medicine; Regenstrief Inst; Roudebush Veterans Admin Medical Center, Indianapolis, Ind.

3:12 Costs and Rehabilitation Utilization of Stroke Patients: A Retrospective Study of Medicare Beneficiaries 91
Richard D. Zorowitz, Johns Hopkins Bayview Medical Center, Baltimore, Md.; Er Chen, Kuo B. Tong, Quorum Consulting, Inc., San Francisco, Calif.

3:24 Discussion

Session IX: Concurrent E
Oral Abstract Presentations: Community/Risk Factors
Room La Louisianne C

Moderators: Robert J.Adams, M.D., Charleston, S.C.
Karen Furie, M.D., FAHA, Boston, Mass.

2 Insulin Resistance and Risk of Ischemic Stroke among Non-Diabetic Individuals from the Northern Manhattan Study 92
Tatjana Rundek, Department of Neurology, Miller School of Medicine, University of Miami, Miami, Fla.; Qiang Xu, Department of Biostatistics, Joseph Miallman School of Public Health, Columbia University, New York, N.Y.; Ronald B. Goldberg, Department of Medicine, Miller School of Medicine, University of Miami, Miami, Fla.; Bernadette Boden-Albala, Department of Neurology and Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, N.Y.; Norbelina Disla, Department of Neurology, Columbia University, New York, N.Y.; Myunghee C. Paik, Department of Biostatistics, Joseph Mailman School of Public Health, Columbia University, New York, N.Y.; Mitchell S. Elkind, Department of Neurology, Columbia University, New York, N.Y.; Ralph L. Sacco, Department of Neurology, Epidemiology and Human Genetics, Miller School of Medicine, University of Miami, Miami, Fla.

2:12 C-Reactive Protein Predicts Recurrent Stroke and Death in a Hyperhomocyst(e)inemic Population 93
Karen L. Furie, Massachusetts General Hospital, Boston, Mass.; Annie G. Howard, Lloyd E. Chambless, Stephen Campbell, University of North Carolina at Chapel Hill, Chapel Hill, N.C.; James F. Toole, Wake Forest University, Winston-Salem, N.C.; Mitchell S. Elkind, Columbia University, New York, N.Y.

2:24 Daytime Sleepiness and Risk of Stroke and Vascular Disease: Findings from the Northern Manhattan Study (NOMAS) 94
Bernadette Boden-Albala, Carl Bazil, Yeseon Moon, Janet De Rosa, Mitchell S. Elkind, Myunghee C. Paik, Columbia University, New York, N.Y.; Ralph L. Sacco, University of Miami, Miami, Fla.

2:36 Stroke in Women - Gender Differences in Stroke Incidence and Post-stroke Disability in the Framingham Heart Study 95
Rodica E. Petrea, Department of Neurology, Boston University School of Medicine, Boston, Mass.; Alexa S. Beiser, Sudha Seshadri, Margaret Kelly-Hayes, Carlos S. Kase, Philip A. Wolf, Department of Neurology, Boston University School of Medicine, Public Health and Framingham Heart Study, Boston, Mass.

2:48 National Utilization of, and Outcomes following, Craniectomy for Space Occupying Cerebral Infarction in the United States 96
Mustapha A. Ezzeddine, Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minn.; Praveen R. Baimeedi, Department of Neurosurgery, University of Minnesota, Minneapolis, Minn.; Abu Nasar, M. Fareed K. Suri, Adnan I. Qureshi, Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minn.

3:00 Gene Variants Previously Associated With Coronary Heart Disease: Association With Incident Ischemic Stroke in the Cardiovascular Health Study 97
May M. Luke, CELERA, Alameda, Calif.; Ellen S. O'Meara, University of Washington, Seattle, Wash.; Charles M. Rowland, Lance A. Bare, Dov Shiffman, CELERA, Alameda, Calif.; Thomas Lumley, Kenneth Rice, University of Washington, Seattle, Wash.; Andre R. Arellano, CELERA, Alameda, Calif.; Russell P. Tracy, University of Vermont, Colchester, Vt.; James J. Devlin, CELERA, Alameda, Calif.; Bruce M. Psaty, University of Washington, Seattle, Wash.

3:12 Analysis of the Age-at-Onset Phenotype in a Pilot Genome-Wide Association Study of Ischemic Stroke 98
Bradford B. Worrall, University of Virginia, Charlottesville, Va.; W. Mark Brown, Wake Forest School of Medicine, Winston-Salem, N.C.; Thomas G. Brott, Mayo Clinic, Jacksonville, Fla.; Robert D. Brown Jr., Mayo Clinic, Rochester, Minn.; John Hardy, Queen Square, London, United Kingdom; Mar Matarin, National Institute of Aging, Bethesda, Md.; Stephen S. Rich, University of Virginia, Charlottesville, Va.; Andrew Singleton, National Institute of Aging, Bethesda, Md.; James F. Meschia, Mayo Clinic, Jacksonville, Fla.; for the Ischemic Stroke Genetics Study (ISGS) Investigators

3:24 Discussion

3:30-4 p.m.
Exhibits/Break
Hall A

4-5:30 p.m.

Session X: Concurrent Symposia A
PPAR-Gamma: A New Target for Stroke?
Room La Louisianne A/B

Moderators: Jaroslaw Aronowski, M.S., Ph.D., Houston, Texas
Frank M. Faraci, Ph.D., FAHA, Iowa City, Iowa

4 PPAR and Molecular Targets in Vascular Biology
Eyal Leibovitz, M.D., Montreal, Canada

4:20 Impact of PPAR-gamma in the Cerebral Circulation
Frank M. Faraci, Ph.D., FAHA, Iowa City, Iowa

4:40 PPAR-gamma and Neuroinflammation
Jaroslaw Aronowski, M.S., Ph.D., Houston, Texas

5 PPAR-gamma Agonists and Acute Stroke Therapy
Maria Moro, Ph.D., Madrid, Spain

5:20 Discussion

Session X: Concurrent Symposia B
Stroke and the Law: Legal Issues in Cerebrovascular Disease
Hall B 2

Moderators: Mark Fisher, M.D., FAHA, Irvine, Calif.
Thomas G. Brott, M.D., Jacksonville, Fla.

4 Principles of Legal Medicine
Mark Fisher, M.D., FAHA, Irvine, Calif.

4:20 Review of Stroke Case Law
Michael I. Weintraub, M.D., Valhalla, N.Y.

4:40 The Impact of New Stroke Evaluation and Treatment on Litigation
John P. Conomy, M.D., Chagrin Falls, Ohio

5 The Impact of Medical Legal Issues on Stroke Treatment
Justin Zivin, M.D., Ph.D., FAHA, La Jolla, Calif.

5:20 Discussion

Session X: Concurrent C
Oral Abstract Presentations: Extracranial Occlusive Disease
Room RO-2

Moderators: Brian Hoh, M.D., Gainesville, Fla.
Avery Evans, Charlottesville, Va.

4 Timing and Type of Neurologic Events prior to Carotid Artery Stenting are Predictors of Stroke 99
Seemant Chaturvedi, Wayne State University, Detroit, Mich.; Richard Atkinson, Sutter Health, Sacramento, Calif.; for the CAPTURE and EXACT Executive Committees

4:12 Neuropsychological Changes After Carotid Stenting With Cerebral Protection 100
Francisco Moniche, Paloma Gonzalez-Perez, Myrta O'Valle, Jose Ramon Gonzalez-Marcos, Alejandro Gonzalez, Aurelio Cayuela, Antonio Mayol, Alberto Gil-Peralta, Hosp. Univ. Virgen del Rocio, Seville, Spain

4:24 High Volume Centers Have Lower Complication Rates After Cea And Cas In The Space Study 101
Peter A. Ringleb, University Clinic of Heidelberg, Heidelberg, Germany; H. H. Eckstein, Clinic Rechts der Isar, Munich, Germany; Marius Hartmann, Werner Hacke, University Clinic of Heidelberg, Heidelberg, Germany; SPACE Investigators

4:36 Extension Of Atherothrombotic Disease To Extracerebral Territories Following Stroke: Inflammation Or Vascular Remodeling Mechanisms? 102
Tomas Sobrino, Miguel Blanco, Department of Neurology, Clinical Neuroscience Res Lab, Hosp Clinico Univrio, Univ of Santiago de Compostela, Santiago de Compostela, Spain; Joan Montaner, Neurovascular Res Lab, Neurovascular Unit, Vall d'Hebron Univ Hosp, Barcelona, Spain; Mara Mar Freij, Dept of Neurology, Hosp de Basurto, Bilbao, Spain; Miguel Angel Llaneza, Dept of Neurology, Hosp Clinico Univrio de Salamanca, Salamanca, Spain; Enrique Corredera, Dept of Neurology, Hosp Meixoeiro, Vigo, Spain; Blanca Fuentes, Dept of Neurology, Hosp Univrio La Paz, Madrid, Spain; Javier Tejada, Dept of Neurology, Hosp de Lein, Lein, Spain; David Conovas, Dept of Neurology, Consorci Hospari del Parc Taul, Barcelona, Spain; Jose Castillo, Dept of Neurology, Clinical Neuroscience Res Lab, Hosp Clinico Univrio, Univ of Santiago de Compostela, Santiago de Compostela, Spain; for the MITICO Study Investigators

4:48 Inflammatory Markers Predicts Future Cardiovascular and Neurological Events In Patient Undergoing Carotid Stent Implantation 103
Francesco Versaci, Costantino Del Giudice, Tor Vergata Univ, Roma, Italy; Achille Gaspardone, Sant'Eugenio Hosp, Roma, Italy; Gian Luigi Condorelli, Istituto di Ricovero e Cura a Carattere Scientifico Multimedica, Roma, Italy; Antonio Pellegrino, Alessandro Mauriello, Laura Liberatoscioli, Igino Proietti, Giovanni Simonetti, Claudio Cortese, Luigi Chiariello, Tor Vergata Univ, Roma, Italy

5 Plaque Characterization by Virtual Histology TM Intravascular Ultrasound Analysis in Symptomatic Internal Carotid Artery Stenosis 104
Shoji Matsumoto, Ichiro Nakahara, Toshio Higashi, Yasushi Iwamuro, Yoshihiko Watanabe, Kenji Takahashi, Tetsuhiro Kikuchi, Mitsushige Ando, Masahiro Takezawa, Masahiro Takezawa, Kokura Memorial Hosp, Kitakyushu-shi, Fukuoka, Japan

5:12 High-Resolution CT Imaging of Carotid Artery Atherosclerotic Plaques 105
Max Wintermark, University of California, San Francisco, Calif.; Sumayya S. Jawadi, University of Missouri, Kansas City, Kan.; Joseph H. Rapp, San Francisco VA Medical Center, San Francisco, Calif.; Tarik Tihan, Elizabeth Tong, David Glidden, University of California, San Francisco, Calif.; Sami Abedin, University of Missouri, Kansas City, Kan.; Sarah Schaeffer, Gabriel Acevedo-Bolton, University of California, San Francisco, Calif.; Benjamin Boudignon, University of California, San Francisco, Calif.; Benjamin Orwoll, University of California, San Francisco, Calif.; XianMang Pan, San Francisco VA Medical Center, San Francisco, Calif.; David Saloner, University of California, San Francisco, Calif.

5:24 Discussion

Session X: Concurrent D
Oral Abstract Presentations: Cranial and Spinal Vascular Malformations
Room RO-6

Moderators: Robert W. Tarr, M.D., Cleveland, Ohio
Kethan Bulsara, New Haven, Conn.

4 Natural History of Dural Arteriovenous Shunts 106
Tommy Andersson, Karolinska Hosp, Stockholm, Sweden; Ladislav Pavic, Univ Hosp Dubrava, Zagreb, Croatia; Goran Edner, Staffan Holmin, Michael Soderman, Karolinska Hosp, Stockholm, Sweden

4:12 Benign Course of Borden Type 2 and 3 Dural Arteriovenous Fistulas Presenting Without Neurological Symptoms 107
James A. Botros, Russell G. Strom, Daniel Refai, Dept of Neurosurgery, Washington University School of Medicine, Saint Louis, Mo.; Colin P. Derdeyn, Depts of Neurosurgery and Neurology and the Mallinckrodt Inst of Radiology, Washington University School of Medicine, Saint Louis, Mo.; Gregory J. Zipfel, Depts of Neurosurgery and Neurology, Washington Univ School of Medicine, Saint Louis, Mo.

4:24 Multimodality Care of Occipital Lobe AVMs: Neurological Outcomes of A Prospective Series of 134 Patients 108
Amir R. Dehdashti, Laurent Thines, Toronto Western Hospital, Neurosurge, Toronto, Ontario, Canada; Robert Willinsky, Toronto Western Hospital, Radiology, Toronto, Ontario, Canada; Michael L. Schwartz, SunnyBrooke Hospital, Neurosurge, Toronto, Ontario, Canada; Karel TerBrugge, Toronto Western Hospital, Radiology, Toronto, Ontario, Canada; Michael Tymianski, M.Christopher Wallace, Toronto Western Hospital, Neurosurge, Toronto, Ontario, Canada

4:36 Brainstem Arteriovenous Malformations: Natural History, Multimodality Management And Long Term Follow-up 109
Laurent Thines, Amir R. Dehdashti, Michael Tymianski, Karel G. TerBrugge, Robert A. Willinsky, Toronto Western Hospital, Toronto, Ontario, Canada; Michael Schwartz, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; M. Christopher Wallace, Toronto Western Hospital, Toronto, Ontario, Canada; University of Toronto Brain Vascular Malformation Study Group

4:48 Plasma Levels of Matrix Metalloproteinases after Treatment for Cerebral Arteriovenous Malformations 110
Robert M. Starke, Ricardo J Komotar, Columbia University, New York, N.Y.; Marc L. Otten, Brian Y. Hwang, David K. Hahn, Laura E. Fischer, Grace H. Kim, Zachary L. Hickman, Mathew C. Garrett, Maxwell B. Merkow, Michal A. Rynkowski, Robert A. Solomon, E. Sander Connolly, Columbia University, New York, N.Y.

5 Inflammatory Cell Infiltration in Cerebral Cavernous Malformations and Lesion Phenotype and Clinical Manifestations 111
Robert Shenkar, Evanston Northwestern, Evanston, Ill.; Harish Raja, Duke University, Durham, N.C.; Hongyan Du, Evanston Northwestern, Evanston, Ill.; Changbin Shi, Northwestern Universtiy, Chicago, lll.; H. Hunt Batjer, Northwestern University, Chicago, Ill.; Issam Awad, Evanston Northwestern, Evanston, Ill.

5:12 Transforming Growth Factor-beta1 Polymorphisms and Risk of Intracranial Hemorrhage in Brain Arteriovenous Malformation Patients 112
Helen Kim, Ludmila Pawlikowska, Charles E. McCulloch, Pui-Yan Kwok, William L. Young, UCSF, San Francisco, Calif.

5:24 Discussion

Session X: Concurrent E
Oral Abstract Presentations: Prevention
Room La Louisianne C

Moderators: Bruce M. Coull, Tucson, Ariz.
Cathy A. Sila, M.D., FAHA, Cleveland, Ohio

4 Gender Differences In The Management Of Cerebrovascular Disease: The Challenge Of Secondary Prevention 113
Gustavo Saposnik, University of Toronto and Mobility Program Clinical Res Unit, Toronto, Ontario, Canada; Andrew Yan, University of Toronto and Canadian Heart Research Center, Toronto, Ontario, Canada; Amparo Casanova, Canadian Heart Research Center, Toronto, Ontario, Canada; Anatoly Langer, University of Toronto and Canadian Heart Research Center, Toronto, Ontario, Canada; Shaun Goodman, University of Toronto and Canadian Heart Research Center, Toronto, Ontario, Canada; for the Stroke Outcome Research Canada (SORCan) Working Group

4:12 Does Differential Prophylactic Aspirin Use Contribute to Racial and Geographic Disparities in Stroke? 114
Stephen P. Glasser, University of Alabama Birmingham, Birmingham, Ala.; Mary Cushman, University of Vermont, Burlington, Vt.; Ronald J. Prineas, Wake Forest University, Winston-Salem, N.C.; Dawn Kleindorfer, University of Cincinnati College of Medicine, Cincinnati, Ohio; Valerie Prince, Samford University McWhorter School of Pharmacy, Birmingham, Ala.; Zhiying You, Virginia J. Howard, George Howard, University of Alabama Birmingham, Birmingham, Ala.; for the REGARDS Investigators

4:24 Adherence eValuation After Ischemic stroke Longitudinal (AVAIL): Identifying Facilitators of Adherence to Stroke Prevention Medications 115
Cheryl Bushnell, Wake Forest University Health Sciences, Winston-Salem, N.C.; Mark Alberts, Northwestern University, Chicago, Ill.; Michael Frankel, Emory University, Atlanta, Ga.; Larry B. Goldstein, Duke University, Durham, N.C.; Philip Gorelick, University of Illinois at Chicago, Chicago, lll.; S. Claiborne Johnston, University of California at San Francisco, San Francisco, Calif.; Chelsea Kidwell, Georgetown University, Washington, D.C.; Lee Schwamm, Harvard University, Boston, Mass.; Linda Williams, Indiana University, Indianapolis, Ind.; Eric Peterson, Duke University, Durham, N.C.

4:36 Atorvastatin is Similarly Effective in All Ischemic Stroke Subtypes: Secondary Analysis of the SPARCL Trial 116
Pierre Amarenco, Denis Diderot University, Paris, France; Oscar Benavente, University of Texas Health Science Center, San Antonio, Texas; Larry B. Goldstein, Duke University Medical Center, Durham, N.C.; Alfred Callahan III, Saint Thomas Hospital, Nashville, Tenn.; Michael G. Hennerici, Univ Heidelberg, Mannheim, Germany; Henrik Sillesen, University of Copenhagen, Copenhagen, Denmark; K. Michael Welch, Rosalind Franklin University of Medicine and Science, Chicago, Ill.; Justin Zivin, University of California, San Diego, San Diego, Calif.; on behalf of the SPARCL Investigators

4:48 Assessing the Net Clinical Benefit of Warfarin by Ischemic Stroke Risk in Atrial Fibrillation: The ATRIA Study 117
Daniel E. Singer, Yuchiao Chang, Massachusetts General Hospital, Boston, Mass.; Margaret C. Fang, University of California, San Francisco, Calif.; Leila H. Borowsky, Massachusetts General Hospital, Boston, Mass.; Niela K. Pomernacki, Natalia Udaltsova, Alan S. Go, Kaiser Permanente of Northern California Division of Res, Oakland, Calif.

5:00 Closure of the Lead-in Phase of CREST (Carotid Revascularization Endarterectomy Vs. Stenting Trial): 30-day And One Year Analyses 118
Robert W. Hobson II, University Med & Dentistry of New Jersey/ N.J. Medical School, Newark, N.J.; Thomas G. Brott, Mayo Clinic, Jacksonville, Fla.; Gary S. Roubin, Krishna Kathir, Lenox Hill, New York, N.Y.; Alice J. Sheffet, University Med & Dentistry of New Jersey/ N.J. Medical School, Newark, N.J.; Pierre Leimgruber, Deaconess Medical Center, Spokane, Wash.; Christopher White, Ochsner Clinic, New Orleans, La.; Munier Nazzal, University of Toledo, Toledo, Ohio; Elie Chakhtoura, St. Michael's Medical Center, Newark, N.J.; B. K. Lal, University of Med & Dentistry of New Jersey/ N.J. Medical School, Newark, N.J.; MeeLee Tom, Susan E. Hughes, University Med & Dentistry of New Jersey/ N.J. Medical School, Newark, N.J.; Mary Longbottom, Mayo Clinic, Jacksonville, Fla.; George Howard, University of Alabama at Birmingham, Birmingham, Ala.; Stephanie Martin, University of Alabama at Brimingham, Birmingham, Ala.; Jenifer H. Voeks, University of Alabama at Birmingham, Birmingham, Ala.

5:12 Cardiorespiratory Fitness as a Predictor of Fatal and Nonfatal Stroke in Asymptomatic Women and Men 119
Steven P. Hooker, Prevention Research Center, University of South Carolina, Columbia, S.C.; Xuemei Sui, Deparment of Exercise Science, University of South Carolina, Columbia, S.C.; Natalie Colabianchi, Department of Epidemiology and Biostatistics and Prevention Research Center, University of South Carolina, Columbia, S.C.; John Vena, James Laditka, Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, S.C.; Michael J. LaMonte, Department of Social and Preventive Medicine, University at Buffalo, Buffalo, N.Y.; Steven N. Blair, Depts of Exercise Science and Epidemiology and Biostatistics, University of South Carolina, Columbia, S.C.

5:24 Discussion

5:30-7:30 p.m.
Poster Session II/Reception
Hall B 1